These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19200433)

  • 1. Extreme creatine phosphokinase elevation in a 20-year-old man participating in a clinical trial of major depressive disorder.
    Shiovitz TM; Song JL; Manlosa NB; Seliverstov MI; Sharma S
    J Clin Psychiatry; 2008 Nov; 69(11):1832-4. PubMed ID: 19200433
    [No Abstract]   [Full Text] [Related]  

  • 2. Missed neuroleptic malignant syndrome.
    Renwick DS; Chandraker A; Bannister P
    BMJ; 1992 Mar; 304(6830):831-2. PubMed ID: 1392715
    [No Abstract]   [Full Text] [Related]  

  • 3. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 4. The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.
    Adityanjee
    Br J Psychiatry; 1991 May; 158():706-7. PubMed ID: 1677602
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant neuroleptic syndrome--a possibility for early diagnosis].
    Rasmussen KT; Scherling A
    Ugeskr Laeger; 1991 Oct; 153(43):3018-9. PubMed ID: 1801391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eccentric exercise and neuroleptic malignant syndrome.
    Gralton E; Wildgoose J; Donovan WM; Wilkie J
    Lancet; 1998 Oct; 352(9134):1114. PubMed ID: 9798588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Agomelatine].
    Tessmer M
    Med Monatsschr Pharm; 2009 Aug; 32(8):282-8. PubMed ID: 19777735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early effects of antidepressants].
    Llorca PM
    Encephale; 2012 Dec; 38 Suppl 2():S49-53. PubMed ID: 23279958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Creatine phosphokinase in a hospitalized psychiatric population].
    Manero Marcén E; Malo Ocejo P; Uriarte Uriarte JJ; Pinilla Tubet E
    Arch Neurobiol (Madr); 1992; 55(5):235-40. PubMed ID: 1362345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome in a patient treated with alimemazine].
    Auffret M; Béné J; Lachatre M; Lambert M; Gautier S
    Therapie; 2013; 68(3):173-4. PubMed ID: 23886464
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Food and Drug Administration.
    Henney JE
    JAMA; 1999 Oct; 282(13):1218. PubMed ID: 10517411
    [No Abstract]   [Full Text] [Related]  

  • 12. Does electroconvulsive therapy exacerbate the elevation of creatinine phosphokinase caused by neuroleptics.
    Geizer M; Ancill R
    Can J Psychiatry; 1996 Mar; 41(2):131. PubMed ID: 8705961
    [No Abstract]   [Full Text] [Related]  

  • 13. Catatonia and creatinine phosphokinase.
    Domken MA; Farquharson RG
    Br J Psychiatry; 1992 Aug; 161():283-4. PubMed ID: 1521134
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome.
    McCarthy A
    Br J Psychiatry; 1989 Jul; 155():127. PubMed ID: 2641996
    [No Abstract]   [Full Text] [Related]  

  • 15. CPK levels and neuroleptic malignant syndrome.
    Maharajh HD
    Br J Psychiatry; 1989 Jun; 154():885-6. PubMed ID: 2597905
    [No Abstract]   [Full Text] [Related]  

  • 16. CPK levels and neuroleptic malignant syndrome.
    James S
    Br J Psychiatry; 1989 Oct; 155():567. PubMed ID: 2611586
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis and the neuroleptic malignant syndrome.
    O'Neill D
    J Am Geriatr Soc; 1992 Dec; 40(12):1288-9. PubMed ID: 1447452
    [No Abstract]   [Full Text] [Related]  

  • 19. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.
    Kennedy SH; Emsley R
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):93-100. PubMed ID: 16249073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome.
    Clarke CE; Shand D; Yuill GM; Green MH
    Lancet; 1989 Jan; 1(8631):221. PubMed ID: 2563130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.